CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $17,224,593
- in 1 filing
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-17 | Londei Marco Chief Medical Officer | Exercise or conversion | +22,000 | $6.93 | $152K | 174,925 |
| 2018-12-17 | Londei Marco Chief Medical Officer | Sale | −12,120 | $65.36 | $792K | 162,805 |
| 2018-12-17 | Londei Marco Chief Medical Officer | Sale | −3,185 | $66.38 | $211K | 159,620 |
| 2018-12-17 | Londei Marco Chief Medical Officer | Sale | −8,002 | $67.57 | $541K | 151,618 |
| 2018-12-17 | Londei Marco Chief Medical Officer | Sale | −6,741 | $68.47 | $462K | 144,877 |
| 2018-12-17 | Londei Marco Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −8,048 | 10,060 | ||
| 2018-12-17 | Londei Marco Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −22,000 | 70,223 | ||
| 2018-12-14 | Suria Hamza President, CEO | Exercise or conversion | +41,728 | $1.12 | $47K | 71,792 |
| 2018-12-14 | Suria Hamza President, CEO | Sale | −24,844 | $68.89 | $1.7M | 46,948 |
| 2018-12-14 | Suria Hamza President, CEO | Sale | −9,084 | $69.68 | $633K | 37,864 |
| 2018-12-14 | Suria Hamza President, CEO | Sale | −7,800 | $70.51 | $550K | 30,064 |
| 2018-12-14 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −41,728 | 129,284 | ||
| 2018-12-12 | Suria Hamza President, CEO | Exercise or conversion | +30,000 | $1.12 | $34K | 60,064 |
| 2018-12-12 | Suria Hamza President, CEO | Sale | −12,003 | $71.11 | $853K | 48,061 |
| 2018-12-12 | Suria Hamza President, CEO | Sale | −9,673 | $71.92 | $696K | 38,388 |
| 2018-12-12 | Suria Hamza President, CEO | Sale | −8,324 | $72.88 | $607K | 30,064 |
| 2018-12-12 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option | −30,000 | 80,361 | ||
| 2018-12-11 | Suria Hamza President, CEO | Sale | −4,998 | $70.83 | $354K | 30,064 |
| 2018-12-10 | Suria Hamza President, CEO | Exercise or conversion | +30,587 | $1.12 | $34K | 65,649 |
| 2018-12-10 | Suria Hamza President, CEO | Sale | −15,276 | $70.57 | $1.1M | 50,373 |
Page 29 of 36 · 714 trades